Mitochondrial Antiviral Signaling Protein (MAVS) Peptide
MAVS
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN938153
382,12 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination:
France
Envoi sous 20 à 27 jours ouvrables
Aperçu rapide pour Mitochondrial Antiviral Signaling Protein (MAVS) Peptide (ABIN938153)
Antigène
MAVS
(Mitochondrial Antiviral Signaling Protein (MAVS))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- ETQAPESPGE NSEQALQTLS PRAIPRNPDG GPLESSSDLA ALSPLTSSGH
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of VISA antibody,
Alternative Names: VISA control peptide, VISA antibody Blocking Peptide, Anti-VISA Blocking Peptide, Virus-Induced Signaling Adapter Blocking Peptide, CARDIF Blocking Peptide, DKFZp666M015 Blocking Peptide, FLJ27482 Blocking Peptide, FLJ41962 Blocking Peptide, IPS-1 Blocking Peptide, KIAA1271 Blocking Peptide, MAVS Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
-
Sujet
- Double-stranded RNA viruses are recognised in a cell type-dependent manner by the transmembrane receptor TLR3 or by the cytoplasmic RNA helicases MDA5 and RIGI (ROBO3). These interactions initiate signaling pathways that differ in their initial steps but converge in the activation of the protein kinases IKKA (CHUK) and IKKB (IKBKB), which activate NFKB, or TBK1 and IKKE (IKBKE), which activate IRF3. Activated IRF3 and NFKB induce transcription of IFNB (IFNB1). For the TLR3 pathway, the intermediary molecule before the pathways converge is the cytoplasmic protein TRIF (TICAM1). For RIGI, the intermediary protein is mitochondria-bound VISA.
-
Poids moléculaire
- 56 kDa
Antigène
-
Vous êtes ici:
